TTS Thomas Starzl Innovation Award

The TTS Starzl Innovation Award is named after Tom Starzl who was best known for his contributions to the field of organ transplantation, and often referred to as the “father of transplantation”. The award recognizes individuals who, though advanced and original work, have contributed significantly to transplantation, thereby reflecting the spirit pioneered by Dr. Starzl.
Application Deadline

May 1, 2022

Supported by
Early in his career, Dr. Starzl recognized the importance of deceased donation. He pioneered many facets of transplantation, including immunosuppressive drug development, organ preservation, tissue matching, surgical transplant technology, and developed the team approach to organ transplantation; thus paving the way for the success and acceptance of heart, lung, pancreas, intestinal, liver, and kidney transplantation. The international impact of the fruits of seven decades of commitment to transplantation is shown by estimates of over 600 000 Americans and millions of patients around the world that have received a life-saving organ transplantation. He was also credited as having trained over 1,000 medical and surgical transplant specialists over his 50 years in clinical medicine, many of whom have gone on to successfully develop their own transplant

Eligibility to Award

All full members in good standing will be eligible to be nominated for this award.

Frequency of Award

The Award will be given at each of the TTS Biennial congresses.

Selection of the Recipient

The Chair of the Selection Committee will be the then current TTS President, who will choose a selection committee of 3 among the Council members.

Monetary Award

The monetary award will be $10,000.

Previous Winners

2020

The Transplantation Society would like to congratulate Andreas G. Tzakis on being the recipient of the 2020 TTS Thomas Starzl Innovation Award.

Dr. Andreas Tzakis has been involved in transplantation for more than 35 years, and has contributed to many of its aspects. He received his education at the University of Athens School of Medicine and National University of Athens in Athens Greece, as well as at SUNY at Stony Brook in New York. He completed his multiorgan transplant fellowship at the University of Pittsburgh.

Dr. Tzakis advanced through the academic ranks at the Universityof Pittsburgh, where he became Professor of Surgery and was Director of the Pediatric Transplant(program at the Children’s Hospital in Pittsburgh (CHP). At this time the pediatric program at CHP was the busiest in the United States, and it developed the first ever successful multivisceral transplant program in the world.

Dr. Tzakis was then recruited as a tenured Professor of Surgery at the University of Miami School of Medicine and Director of the Transplant Program at Jackson Memorial Hospital. He then joined the Cleveland Clinic Florida as the Director of Abdominal Transplantation in 2012. He is also Professor of Surgery at the Cleveland Clinic Lerner College of Medicine.

Dr. Tzakis has been a member of notable scientific and professional societies and has held leadership positions in those societies, serving on the Council of the International Pediatric Transplant Association, as President of the Intestinal Transplant Association, and Councilor of the Transplantation Society.

Dr. Tzakis has published over 700 publications, 40 book chapters and numerous abstracts. He has received funding from the NIH, CTOT/ITN and industry.

During his career, Dr. Tzakis has contributed to many aspects of transplantation, including:

  • description and reporting of the first series of piggyback liver transplants obviating the need for veno-venous bypass
  • developing intestinal transplantation in children;
  • advancing the use of immunosuppressive protocols, including an important role in tacrolimus testing;
  • transplantation of HIV positive recipients;
  • demonstrating the utility of donor derived NK cells in minimizing HCC recurrence;
  • tolerance protocols with one of the largest immunosuppression-free liver transplant populations in the world;
  • developing abdominal wall composite tissue transplantation, and most recently;
  • preclinical and clinical advances in uterine transplantation with an overall success rate of live birth.

In the latter effort, he was a key member in the preclinical primate studies and working with the Swedish group analyzing anatomy, vasculature and logistics before embarking on the clinical trial demonstrating the utility of uterine transplantation with an overall success rate of live birth pregnancies of 70%. Dr. Tzakis organized and performed the first successful cadaveric uterine transplant at the Cleveland Clinic.

Lastly, Dr. Tzakis has been a consummate teacher, having trained more than 200 surgeons, many of whom have gone on to lead their own programs around the world.


Thomas Starzl at the second TTS Congress (pictured in the middle row between Joseph Murray and Ray Owen).

Social

Contact

Staff Directory
+1-514-874-1717
info@tts.org

Address

The Transplantation Society
International Headquarters
505 Boulevard René-Lévesque Ouest
Suite 1401
Montréal, QC, H2Z 1Y7
Canada